These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7939432)

  • 41. Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.
    Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
    Drugs Exp Clin Res; 1992; 18(8):311-7. PubMed ID: 1338041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase production.
    Martínez-Martínez L; Pascual A; Conejo Mdel C; García I; Joyanes P; Doménech-Sánchez A; Benedí VJ
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3926-32. PubMed ID: 12435697
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe.
    Brisse S; Milatovic D; Fluit AC; Verhoef J; Schmitz FJ
    Eur J Clin Microbiol Infect Dis; 2000 Jan; 19(1):64-8. PubMed ID: 10706185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Relationship between the sensitivity of Pseudomonas aeruginosa and the post-antibiotic effect of sparfloxacin and ciprofloxacin].
    Pastor A; Cantón E; Pemán J
    Rev Esp Quimioter; 1998 Dec; 11(4):333-8. PubMed ID: 9990147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of low-level resistance to ciprofloxacin in Klebsiella pneumoniae and the effect of increased dosage of ciprofloxacin in vivo using the rat granuloma pouch model.
    Fuursted K; Schumacher H
    J Antimicrob Chemother; 2002 Sep; 50(3):421-4. PubMed ID: 12205069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone.
    Wise R; Andrews JM; Brenwald N
    J Antimicrob Chemother; 1993 Apr; 31(4):497-504. PubMed ID: 8390433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quinolone resistance from a transferable plasmid.
    Martínez-Martínez L; Pascual A; Jacoby GA
    Lancet; 1998 Mar; 351(9105):797-9. PubMed ID: 9519952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The effect of subinhibitory concentrations of norfloxacin, erythromycin and roxithromycin on Pseudomonas aeruginosa virulence factors].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1995 Sep; 44(3):115-7. PubMed ID: 7489133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro activity of four fluoroquinolones against clinical isolates of Pseudomonas aeruginosa determined by the E test.
    Swiatlo E; Moore E; Watt J; McDaniel LS
    Int J Antimicrob Agents; 2000 Jun; 15(1):73-6. PubMed ID: 10856680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.
    Gargallo D; Moros M; Coll R; Esteve M; Parés J; Xicota MA; Guinea J
    Antimicrob Agents Chemother; 1988 May; 32(5):636-41. PubMed ID: 3134844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased susceptibility of Pseudomonas aeruginosa to ciprofloxacin in the presence of vancomycin.
    Day CA; Marceau-Day ML; Day DF
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2506-8. PubMed ID: 8285646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe.
    Ogle JW; Reller LB; Vasil ML
    J Infect Dis; 1988 Apr; 157(4):743-8. PubMed ID: 3126247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
    Digranes A; Dibb WL; Benonisen E
    Chemotherapy; 1985; 31(6):466-71. PubMed ID: 2934234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.
    Kotera Y; Inoue Y; Ohashi M; Ito K; Tsukamoto G
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2644-6. PubMed ID: 1666861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of two multidrug-resistant Klebsiella species in an Indian teaching hospital and adjoining community.
    Rath S; Padhy RN
    J Infect Public Health; 2014; 7(6):496-507. PubMed ID: 24996691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data.
    Lõivukene K; Sepp E; Adamson V; Mitt P; Kallandi U; Otter K; Naaber P
    Scand J Infect Dis; 2006; 38(11-12):1001-8. PubMed ID: 17148068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.
    Chamberland S; Bayer AS; Schollaardt T; Wong SA; Bryan LE
    Antimicrob Agents Chemother; 1989 May; 33(5):624-34. PubMed ID: 2502066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin.
    Prescott JF; Yielding KM
    Can J Vet Res; 1990 Jan; 54(1):195-7. PubMed ID: 2306672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.